Regulation of endometrial cell proliferation by estrogen-induced BDNF signaling pathway
article
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
Estrogen-induced BDNF signaling, involving STAT3, promotes endometrial cell proliferation, with the Val66Met polymorphism acting as a loss-of-function variant.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin growth factors family. Recent studies indicated that the level of BDNF in follicular fluid is a marker for oocyte quality and infertility. Here, we intend to further investigate the function of BDNF and its signaling pathway in the regulation of endometrial cells proliferation. We found that BDNF is a critical growth factor in endometrial cells. Activation of signal transducer and activator of transcription 3 signaling pathway is required for BNDF-regulated endometrial cell proliferation. Furthermore, BDNF is an effector of estrogen in endometrial cells. Finally, we investigated the different role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNFV66M polymorphism is a loss-of-function polymorphism in the regulation of endometrial cells growth. Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial cells proliferation and to develop new therapeutic strategies for the treatment of endometriosis-related infertility.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Brain-derived neurotrophic factor in plasma of women with endometriosis via openalex
- Brain-Derived Neurotrophic Factor in Plasma of Women with Endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- W1990311482 via openalex
- W1993870556 via openalex
- W2021733324 via openalex
- W2050042714 via openalex
- W2053287079 via openalex
- W2054985002 via openalex
- W95485003 via openalex
- W2070440859 via openalex
- W2076894554 via openalex
- W2079190330 via openalex
- W2130417276 via openalex
- W2134600243 via openalex
- W2139565721 via openalex
- W2140786721 via openalex
- W2150517983 via openalex
- W2161379096 via openalex
- W2059192510 via openalex
- W1963539721 via openalex
- W1970378578 via openalex
Cited by (10)
- BDNF facilitates ectopic endometrial stromal cell growth, invasion, migration and glycolysis in endometriosis via upregulating GLUT1 2026
- The Effect of Endometriosis on the Quality of Oocytes and Embryos Obtained by IVF 2024
- Development and Validation of a novel <i>in vitro</i> diagnostic test for endometriosis 2023
- Brain Derived Neurotrophin Factor (BDNF) as a clinical marker of endometriosis 2023
- Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables 2023
- Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis 2022
- Identification of Potential Molecular Mechanism Related to Infertile Endometriosis 2022
- The role of peripheral nerve signaling in endometriosis 2021
- Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology–Based Identification 2020
- Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain 2017
Source provenance
- europepmc
- last seen: 2026-09-13T09:25:22.628771+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:31.759405+00:00
License: CC0
· commercial use OK